|
End-of-day quote
Shanghai S.E.
06/11/2026
|
5-day change | 1st Jan Change | ||
| 3.200 CNY | -2.14% |
|
+0.31% | -19.60% |
| Market Cap | 2.51B 376M 337M 308M 281M 530M 35.33B 547M 3.71B 1.48B 18.85B 1.41B 1.38B 59.51B | P/E 2024 |
-8.86x | P/E 2025 | -9.48x |
|---|---|---|---|---|---|
| Enterprise Value | 2.73B 408M 366M 335M 306M 576M 38.39B 594M 4.03B 1.61B 20.48B 1.53B 1.5B 64.66B | EV / Sales 2024 |
1.48x | EV / Sales 2025 | 1.79x |
| Free-Float |
69.26% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -2.14% | ||
| 1 week | +0.31% | ||
| Current month | +0.31% | ||
| 1 month | -12.09% | ||
| 3 months | -9.35% | ||
| 6 months | -21.38% | ||
| Current year | -19.60% |
| 1 week | 3.08 |  | 3.28 |
| 1 month | 3.08 | | 3.7 |
| Current year | 2.85 | | 5.27 |
| 1 year | 2.85 | | 5.27 |
| 3 years | 2.76 | | 6.15 |
| 5 years | 2.76 | | 8.8 |
| 10 years | 2.76 | | 20.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ya Qi Dou
CEO | Chief Executive Officer | 42 | 13/05/2021 |
Xianti Zeng
DFI | Director of Finance/CFO | 52 | 06/09/2024 |
Zhi Wei Wang
PRN | Corporate Officer/Principal | 56 | 17/09/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Qi Ling Dou
CHM | Chairman | 66 | 22/01/2009 |
Zhi Wei Wang
BRD | Director/Board Member | 56 | 21/02/2011 |
Ya Qi Dou
BRD | Director/Board Member | 42 | 03/01/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.14% | +0.31% | -25.58% | -45.02% | 384M | |
| -0.79% | -4.48% | +44.44% | +127.49% | 1,216B | |
| +1.43% | +1.11% | +47.73% | +82.08% | 656B | |
| +1.07% | -1.21% | +32.99% | +106.31% | 509B | |
| -0.36% | -3.25% | +47.17% | +64.58% | 384B | |
| -0.14% | -1.87% | +71.05% | +40.63% | 362B | |
| -0.78% | -0.52% | +30.57% | +57.98% | 311B | |
| -0.80% | -0.21% | +8.54% | +35.56% | 293B | |
| +0.03% | -1.20% | +45.89% | +68.76% | 249B | |
| -0.41% | -2.22% | +35.24% | +105.68% | 208B | |
| Average | -0.29% | -0.28% | +33.81% | +64.40% | 418.82B | |
| Weighted average by Cap. | -0.05% | -1.21% | +42.19% | +88.34% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.17B 326M 292M 267M 244M 459M 30.6B 473M 3.22B 1.28B 16.33B 1.22B 1.2B 51.55B | 1.86B 279M 250M 229M 209M 393M 26.22B 406M 2.76B 1.1B 13.99B 1.05B 1.02B 44.17B |
| Net income | -317M -47.5M -42.6M -38.93M -35.54M -66.96M -4.47B -69.07M -469M -187M -2.38B -178M -174M -7.52B | -330M -49.35M -44.26M -40.45M -36.92M -69.57M -4.64B -71.76M -488M -194M -2.48B -185M -181M -7.81B |
| Net Debt | 411M 61.52M 55.18M 50.43M 46.04M 86.74M 5.78B 89.47M 608M 242M 3.09B 231M 226M 9.74B | 217M 32.51M 29.16M 26.65M 24.33M 45.83M 3.06B 47.28M 321M 128M 1.63B 122M 119M 5.15B |
Employees
4,832
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/11/26 | CN¥3.200 | -2.14% | 15,488,000 |
| 05/11/26 | CN¥3.270 | +1.24% | 16,164,230 |
| 04/11/26 | CN¥3.230 | +0.94% | 17,180,400 |
| 03/11/26 | CN¥3.200 | +0.63% | 12,703,300 |
| 02/11/26 | CN¥3.180 | -0.31% | 16,602,700 |
- Stock Market
- Stocks
- 600594 Stock
Select your edition
All financial news and data tailored to specific country editions
